FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← RARE · Ultragenyx Pharmaceutical Inc.
DEFA14AThe Ballot

Ultragenyx Pharmaceutical Inc. files DEFA14A

Filed Apr 30, 2026 · 2mo ago · Accession 0001515673-26-000004

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Ultragenyx Pharmaceutical Inc.
Ticker
RARE
CIK
1515673
Form type
DEFA14A
Filing date
Apr 30, 2026
Report date
—
Document
rare_2026_04_30_def14a.htm
Size
1.5 MB

More from RARE

8-KExecutive Change · Shareholder VoteMay 18, 202610-QThe RecordMay 6, 20268-KResults of OperationsMay 5, 20268-KCompany UpdateApr 2, 20268-KCompany UpdateMar 30, 2026DEF 14ADEFINITIVE PROXY STATEMENTMar 27, 2026